Atelerix Ltd is pioneering an innovative platform technology for preserving biological materials at room temperature using alginate hydrogels. They are transforming the preservation and transport of cells, tissues, and viruses by eliminating the need for expensive cold-chain logistics while maintaining sample viability. The company has secured strong intellectual property protection across major markets and validated its technology through collaborations with leading life science organizations.
Status | Active |
Website | https://www.atelerix.co.uk/ |
Category | Enablers |
Modality | Biological and Cell |
Therapautics Area | Multitherapeutics |
Headquaters | Newcastle |
Investment Portfolio | Fund Investment |
Co-Investors | ACF Ventures |